Patheon N.V.

General Information
Business:

Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. We provide a comprehensive, integrated and highly customizable range of active pharmaceutical ingredient, or API, and finished drug product services to our customers, from formulation development to clinical and commercial-scale manufacturing, packaging, and life cycle management. Our services address both small molecule and large molecule biological drugs.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 8800
Founded: 1988
Contact Information
Address Herengracht 483, 1017BT, Amsterdam, The Netherlands
Phone Number +31 (0)20 622 3243
Web Address http://www.patheon.com
View Prospectus: Patheon N.V.
Financial Information
Market Cap
Revenues $1784.8 mil (last 12 months)
Net Income $9.7 mil (last 12 months)
IPO Profile
Symbol PTHN
Exchange NYSE
Shares (millions): 29.8
Price range $21.00 - $21.00
Est. $ Volume $625.0 mil
Manager / Joint Managers J.P. Morgan/ Morgan Stanley/ Jefferies/ UBS Investment Bank/ Credit Suisse/ Evercore ISI/ Wells Fargo Securities
CO-Managers Baird/ Piper Jaffray/ Raymond James/ William Blair/ KeyBanc Capital Markets/ Leerink Partners
Expected To Trade: 7/21/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change